Wells Fargo’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $261K | Buy |
23,005
+5,325
| +30% | +$60.4K | ﹤0.01% | 4226 |
|
2025
Q1 | $118K | Buy |
17,680
+894
| +5% | +$5.95K | ﹤0.01% | 4577 |
|
2024
Q4 | $185K | Buy |
16,786
+5,682
| +51% | +$62.7K | ﹤0.01% | 4357 |
|
2024
Q3 | $136K | Sell |
11,104
-283
| -2% | -$3.48K | ﹤0.01% | 4438 |
|
2024
Q2 | $154K | Buy |
11,387
+1,535
| +16% | +$20.7K | ﹤0.01% | 4325 |
|
2024
Q1 | $133K | Buy |
9,852
+1,352
| +16% | +$18.3K | ﹤0.01% | 4357 |
|
2023
Q4 | $44.7K | Buy |
8,500
+1,682
| +25% | +$8.85K | ﹤0.01% | 4896 |
|
2023
Q3 | $26.9K | Sell |
6,818
-3,689
| -35% | -$14.5K | ﹤0.01% | 5114 |
|
2023
Q2 | $112K | Buy |
10,507
+6,516
| +163% | +$69.3K | ﹤0.01% | 4706 |
|
2023
Q1 | $33.2K | Buy |
3,991
+3,891
| +3,891% | +$32.4K | ﹤0.01% | 5087 |
|
2022
Q4 | $923 | Sell |
100
-244
| -71% | -$2.25K | ﹤0.01% | 5882 |
|
2022
Q3 | $5K | Sell |
344
-231
| -40% | -$3.36K | ﹤0.01% | 5599 |
|
2022
Q2 | $8K | Sell |
575
-980
| -63% | -$13.6K | ﹤0.01% | 5556 |
|
2022
Q1 | $33K | Sell |
1,555
-6,486
| -81% | -$138K | ﹤0.01% | 5491 |
|
2021
Q4 | $193K | Sell |
8,041
-3,034
| -27% | -$72.8K | ﹤0.01% | 4920 |
|
2021
Q3 | $282K | Buy |
11,075
+6,046
| +120% | +$154K | ﹤0.01% | 4680 |
|
2021
Q2 | $169K | Sell |
5,029
-6,387
| -56% | -$215K | ﹤0.01% | 4797 |
|
2021
Q1 | $444K | Buy |
11,416
+3,386
| +42% | +$132K | ﹤0.01% | 4447 |
|
2020
Q4 | $497K | Buy |
8,030
+2,330
| +41% | +$144K | ﹤0.01% | 4440 |
|
2020
Q3 | $191K | Sell |
5,700
-4,571
| -45% | -$153K | ﹤0.01% | 4813 |
|
2020
Q2 | $245K | Sell |
10,271
-10,939
| -52% | -$261K | ﹤0.01% | 4640 |
|
2020
Q1 | $486K | Buy |
21,210
+3,180
| +18% | +$72.9K | ﹤0.01% | 3935 |
|
2019
Q4 | $510K | Buy |
18,030
+14,589
| +424% | +$413K | ﹤0.01% | 4249 |
|
2019
Q3 | $74K | Buy |
+3,441
| New | +$74K | ﹤0.01% | 5182 |
|